Get started
Laurus Labs Ltd.Laurus Labs Ltd.Laurus Labs Ltd.

Laurus Labs Ltd.

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsForecastSeasonalsOptionsETFs

LAURUSLABS trade ideas

Laurus Labs Ltd | Pharma multibagger momentum stockLaurus Labs Ltd | Pharma multibagger momentum stock Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs) Financial: excellent Market Cap = 23,185 Cr. ROCE = 22.2 % ROE = 20.4 % Debt to equity = 0.45 Promoter holding = 27.2 % Piotroski score = 5.00 Quick ratio = 0.64 Current ratio = 1.31 Profit Var 3Yrs = 41.6 % Sales growth 3Years = 27.3 % Return on assets = 11.2 % in sector rotation now its pharma time to move up. big player heavily buying in pharma sector. this stock is big one momentum stock. since long consolidation RSI up move in momentum zone. we have to ready for participate and grab the opportunity . moreover financially also stable pharma company. Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation. If you like my ideas than like boost and follow me for more ideas. Thanks and comment freely
NSE:LAURUSLABSLong
by Momentuminvesting5540
LAURUSLABS | Swing Trade📊 DETAILS Sector: Pharmaceuticals & Drugs Mkt Cap: 21,545 cr Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing. Laurus employs 6500+ people, including around 1050+ scientists at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc. TTM PE : 58.61 (High PE) Sector PE : 47.13 Beta : 0.73 📚 INSIGHTS Mid range performer Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest. 7.73% away from 52 week high Underperformer - Laurus Labs up by 4.26% v/s NIFTY 50 up by 8.74% in last 1 month 📈 FINANCIALS Piotroski Score of 5/9 indicates Average Financials Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst. If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you. 🔍 More Analysis & Trade Setups 🔍 For more technical analysis and trade setups, make sure to follow me on TradingView: www.tradingview.com
NSE:LAURUSLABSLong
by Munish_Jain